SCHEMBL19296459

SCHEMBL19296459

c1ccc(-c2ccc3c(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)c4ccccc4c(-c4ccc5cc6ccccc6cc5c4)c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ESR1 P03372 6/20 0.38
ESR2 Q92731 6/20 0.38
KMT2A Q03164 1/20 0.37
HDAC4 P56524 1/20 0.37
NR3C1 P04150 1/20 0.35
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35
PRSS1 P07477 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
HSD17B1 P14061 1/20 0.35
CYP2B6 P20813 1/20 0.35
CYP2C19 P33261 1/20 0.35
HSD17B2 P37059 1/20 0.35
TSPO P30536 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19296453 0.96 KDM4E (0.44) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL19296461 0.96 KDM4E (0.42) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL12571840 0.95 KDM4E (0.42) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL19296498 0.95 KDM4E (0.39) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL19296491 0.95 KDM4E (0.39) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL13669352 0.95 KDM4E (0.42) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL19296475 0.95 KDM4E (0.39) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL11910822 0.95 KDM4E (0.42) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL19296454 0.95 KDM4E (0.41) KDM4EATML3MBTL1ESR1ESR2
SCHEMBL19296458 0.95 KDM4E (0.41) KDM4EATML3MBTL1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10636976-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-04-28 US disclosed
US-20170250346-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-08-31 US disclosed
US-20170250346-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2017-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10636976-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device TTI1, TTI2, TERF2 KDM4E 2570/4885ATM 309/4885L3MBTL1 267/4885
US-20170250346-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE TTI1, TTI2, TERF2 KDM4E 2570/4885ATM 309/4885L3MBTL1 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.